Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca’s Tagrisso with chemo approved in China as 1st-line treatment
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy reduced the risk of disease progression or death by…
Cipla signs agreement with Takeda to commercialise Vonoprazan
This deal is meant to commercialise the drug in India under Cipla’s own trademark brands
Neurolief announces results from clinical trial of brain neuromodulation system
Neurolief previously received Breakthrough Device designation from the FDA for its technology targeting Major Depression
FDA awards record number of review designations to mRNA vaccines in 2023: GlobalData
Following FDA approval in August 2021, Pfizer’s Comirnaty became the first mRNA vaccine to enter the global market, followed by…
SPDS announces 12th annual conference, Disso India Ahmedabad 2024
The conference will be attended by pharmaceutical R&D, QA, QC professionals to discuss dissolution science and its…
Merck discontinues Phase III TrilynX Study in locally advanced head and neck cancer
The decision follows a pre-planned interim analysis which found that the trial would be unlikely to meet its primary objective of…
Bayer’s BAY2927088 to face competition in EGFR-mutant but limited competition in HER2-exon 20 mutant…
BAY2927088 is an oral, tyrosine kinase inhibitor (TKI) that inhibits mutant HER2, including HER2 exon 20 insertions and HER2 point…
Emmes, ILiAD partner to conduct Phase III clinical trials of Pertussis vaccine
Veridix AI, part of Emmes Group, to provide Advantage eClinical and other platform capabilities critical to accelerate and improve…
Experts shed light on AMR at EuroAsia 2024
Data suggests that 1.2 million deaths in India are due to antimicrobial resistance (AMR), with an estimated 10 million deaths by…
Sun Pharma completes Taro merger
Sun Pharma has been the majority shareholder of Taro since 2010